CoChat

Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine

Open access
Bradley, Todd, Grundberg, Elin, Selvarangan, Rangaraj, LeMaster, Cas, Fraley, Elizabeth, Banerjee, Dithi, Belden, Bradley, Louiselle, Daniel, Nolte, Nick, Biswell, Rebecca, Pastinen, Tomi, Myers, Angela, Schuster, Jennifer · 2021 · New England Journal of Medicine
Cited by 155

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Antibody Responses after a Single Dose of SARS-CoV-2 mRNA VaccineTo the Editor: Currently, two vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that involve messenger RNA (mRNA) platform technology have been approved for emergency use by the Food and Drug Administration (FDA) (mRNA-1273, Moderna; and BNT162b2, Pfizer). 1,2Phase 3 trials of these vaccines showed greater than 90% efficacy at preventing symptomatic infection after two doses administered 3 to 4 weeks apart.These trials primarily involved participants without previous SARS-CoV-2 infection.More than 26 million cases of coronavirus disease 2019 (Covid-19) have been documented in the United States, and high rates of seropositivity have been observed in recent studies. 3Thus, the immune response to vaccination in persons with previous SARS-CoV-2 infection needs to be defined.In this study, we determined antibody levels at baseline and 3 weeks after the first dose of the BNT162b2 SARS-CoV-2 mRNA vaccine in 36 health care workers who received laboratory confirmation of SARS-CoV-2 infection 30 to 60 days before they received the vaccine and 152 health care workers without a history of SARS-CoV-2 infection (Table S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org).The biospecimens from vaccine recipients were obtained in the context of a clinical study at Children's Mercy Kansas City, and their use was reviewed and approved by the Children's Mercy institutional review board.The requirement for written informed consent was waived, given that participants self-enrolled after they had reviewed a study information letter and were given the opportunity to ask questions.Using a multiplex bead-binding assay (Milliplex

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc2102051

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 155

Metadata

Authors
Bradley, T., Grundberg, E., Selvarangan, R., LeMaster, C., Fraley, E., Banerjee, D., Belden, B., Louiselle, D., Nolte, N., Biswell, R., Pastinen, T., Myers, A., & Schuster, J.
Venue
New England Journal of Medicine
Published
2021-05-20
Volume
384
Issue
20
Pages
1959-1961
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3136836696
Cited by
155
References
3
FWCI
10.96
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine. https://app.cochat.ai/papers/10.1056/nejmc2102051
The paper
Bradley, T., Grundberg, E., Selvarangan, R., LeMaster, C., Fraley, E., Banerjee, D., Belden, B., Louiselle, D., Nolte, N., Biswell, R., Pastinen, T., Myers, A., & Schuster, J. (2021). Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine. New England Journal of Medicine. https://doi.org/10.1056/nejmc2102051

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.